OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with ...
Zacks Small Cap Research on MSN
DWTX: Interim Readout for Halneuron® Phase 2b Trial in CINP in 4Q25…
DWTX READ THE FULL DWTX RESEARCH REPORT Business Update 100 Patients Enrolled in Phase 2b Trial of Halneuron®; Interim Analysis in 4Q25 Dogwood Therapeutics, Inc. (NASDAQ:DWTX) is currently conducting ...
OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to tre ...
Purpose: To describe the anatomical aspects of the cervical rootlets and to quantify the number of rootlets that compose C1 to T1. Methods: Twenty male rats were used in this study. The dorsal ...
A scientific footnote from 1922 is now a potential key to treating diabetic nerve pain, a chronic and widespread condition with few effective options. The new study wouldn't have happened without the ...
Bioinformatics and statistical analysis of peer-reviewed papers in Dr. Martha Bhattacharya's lab at the University of Arizona. Overlaps with Itch, Endo, and Hippo repos ...
The Dorsal Root Ganglia (DRG) are a collection of cell bodies of different primary afferent neurons, which lie between vertebrae. Each is surrounded by a layer of satellite glia and resident and ...
Spinal cord and dorsal root ganglion stimulation are established, safe treatments for chronic pain, but they carry a high explantation risk over a long-term period. The long-term explantation risks ...
Renal afferent nerves are reported to mediate the progression of hypertension in preclinical models, putatively via an aberrant increase in activation. The underlying source of this nerve activation ...
This important study expands our understanding of the role of two axon guidance factors in a specific axon guidance decision. The strength of the study is the compelling axonal labeling and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results